Tag Archive for ‘$SNSS’

Cyclacel Pharmaceuticals (CYCC) is a development-stage biopharmaceutical company engaged in the discovery, development and commercialization of mechanism-targeted drugs to treat human cancers and other serious disorders. The Company focuses primarily on the development of orally available anticancer agents that target the cell cycle with the aim of slowing the progression or shrinking the size of tumors. Sapacitabine (CYC682), a cell - Continue Reading »

I am not a pharma expert, but I do dabble in it.  I probably should become one.  Pharma stocks seem to dominate the boards at times.  I think the company, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) should be on your pharma radar.  It is a penny stock now, but they have grand plans. Let’s talk about the bad stuff first: **  SNSS - Continue Reading »